Lots of big losers this week, the worst of which was TEK:Tekcapital dropping 11%. This one's in the trading account and a prime example of not letting posts on bulletin boards entice you into a company that you shouldn't have touched with a barge-pole. All the other similar IP investment shares are doing rubbish, and so is this one.
AMYT:Amryt Pharma dropped 10% for no apparent reason and is now back to making a loss
I thought CEY:Centamin had dropped as far as it was likely to when I bought it a few months back, but it's dropped 30% since then and 9% of that was this week.
RED:RedT Energy looked like it was on the way back to profit, but the last few weeks has been dropping relentlessly and fell 6% this week.
IKA:Ilika continues to slide based on no news whatsoever. It also fell 6% this week and is now 65% own. It's going to take a miracle to prevent wipe-out for this one, but it was a tiny investment.
TLOU:Tlou Energy also dropped 6% as the no-news slide continues. This is 34% down now from a price I considered a bargain when I first bought. What was that rule about falling knives?
Only three decent percentage risers this week. RDT:Rosslyn Data climbed 7% and there's a little momentum here now they seem to be winning more contracts. Still 57% down, but maybe a glimmer of hope. It's another tiny investment though.
PAF:Pan African Resources had a great week, with drilling results from a new project looking brilliant and a new mine about to start producing. The 10% rise will hopefully be just a starter as these were twice the current price not long ago and have continued to be profitable even on low gold prices. They are now 7% up and providing a rare patch of green in the portfolio.
Share of the Week is TAP:Taptica, with excellent results and a climb of 14% putting them 22% up in my trading account. I think they have quite a long way to go before losing steam, so I won't be selling just yet. When I do, it will put the trading account in profit, as they are up £111 and I only need £65 to get into the black.
It's quite nice to have a few weeks of consolidation at this new level. Hoping for a reduction in volatility over the next few weeks.
Here's the performance of the ISA and share portfolios
| Weekly Change | |||
| Cash | £6.61 | -£3.75 | |
| Portfolio cost | £56,958.55 | +£0 | |
| Portfolio sell value (bid price - commission) | £66,902.57 | (17.5%) | +£62.07 |
| Potential profits | £17,467.51 | +£508.02 | |
| Yr 4 Dividends | £29.56 | +£0 | |
| Yr 4 Profit from sales | £814.53 | +£0 | |
| Yr 4 Average monthly cash profit | £725.04 | (15.3%) | -£185.33 |
| Total Dividends | £1,267.89 | +£0 | |
| Total Profit from sales | £19,511.65 | +£0 | |
| Average monthly cash profit | £555.14 | (11.7%) | -£3.57 |
| (Sold stocks profit + Dividends - Fees / Months) |
Monthly charge taken from cash, potential profits up mostly thanks to OPTI:Optibiotix, but deepening losses elsewhere wiped most of it out. Year 4 stats are still a bit mad thanks to the big sell in week 1, as we're only on week 5.
Same as the last chart.
Here's the SIPP after week 145
| Weekly Change | |||
| Cash | £42.83 | -£13.17 | |
| Portfolio cost | £27,893.76 | +£0 | |
| Portfolio sell value (bid price - commission) | £34,230.91 | (22.7%) | +£269.41 |
| Potential profits | £9,428.60 | +£254.86 | |
| Yr 3 Dividends | £292.57 | +£0 | |
| Yr 3 Profit from sales | £1,619.73 | +£0 | |
| Yr 3 Average monthly cash profit | £190.40 | (8.2%) | -£6.19 |
| Total Dividends | £1,208.67 | +£0 | |
| Total Profit from sales | £10,544.92 | +£0 | |
| Average monthly cash profit | £343.53 | (14.8%) | -£2.78 |
| (Sold stocks profit + Dividends - Fees / Months) |
Similar story here, with monthly charges reducing cash and the big rise in PAF:Pan African Resources helping offset the deepening losses elsewhere. Year 3 performance is below target, but long term average is still well over the 10%.
Once again, remarkably similar to the chart above.
Here's the trading portfolio after week 111
| Weekly Change | |||
| Cash | £151.47 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,934.31 | (-16.7%) | +£2.28 |
| Potential profits | £111.36 | +£73.92 | |
| Year 3 Dividends | £0 | +£0 | |
| Year 3 Profit | £177.06 | +£0 | |
| Yr 3 Average monthly cash profit | £109.61 | (56.7%) | -£18.27 |
| Dividends | £1.15 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£2.46 | (-1.3%) | +£0.03 |
| (Sold stocks profit + Dividends - Fees / Months) |
TAP:Taptica is rising very nicely which helped mitigate the losses from other stocks. I think it may have a few more weeks to run before I sell. No change anywhere else.
Value still well below the amount of cash I piled in to begin with.
That's it for this week. I'm late writing so will avoid musings of what might happen next week. we'll just have to wait and see...
No comments:
Post a Comment